FindTrial
Sign In

Effectiveness of individualized Homoeopathic medicine selected on the basis of symptom similarity in the treatment of Contact Dermatitis. Here I am giving individualized Homoeopathic medicine to each and every patient with out any blinding.

A synopsis on Effectiveness of Individualized Homoeopathic medicine in the treatment of Contact Dermatitis: An open label prospective clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044355
Enrollment
30
Registered
2022-07-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L259- Unspecified contact dermatitis, unspecified cause

Interventions

Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINE: AFTER PROPER CASETAKING OF ALL THE PATIENT HAVING CONTACT DERMATITIS WILL BE PRESCRIBED WITH INDIVIDUALIZED HOMOEOPATHIC MEDICINE BASED UPON SYMPTO

Sponsors

National Institute Of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from CD for 1 year or longer 2. Age 18 to 65 years 3. Both sexes 4. Patients willing to give written informed consent 5. Patients already undergoing regular oral/topical conventional therapy for C.D may be recruited only if the medications are stopped completely 3 months prior to the treatment.

Exclusion criteria

Exclusion criteria: 1. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life- threatening illness 2. Substance abuse and/or dependence 3. Patient under the treatment of any other therapy

Design outcomes

Primary

MeasureTime frame
The assessment of the outcome of the treatment will be done by the changes. that occur in the scoring for the Atopic Dermatitis using SCORAD Index.Timepoint: Scoring for the Atopic Dermatitis using SCORAD Index will be assessed at baseline, 3 months and 6 months—

Secondary

MeasureTime frame
The assessment of the outcome of the treatment will be done by the changes. that occur in the Dermatology Life Quality Index (DLQI)Timepoint: Dermatology Life Quality Index (DLQI) will be assessed at baseline, 3 months and 6 months—

Countries

India

Contacts

Public ContactShyamaghana Barik

National Institute Of Homoeopathy

ushauchat@gmail.com9830966265

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026